secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACTUATE THERAPEUTICS, INC. (ACTU)
CIK:        0001652935
Form:       8-K
Filed at:   2024-08-14T23:59:59+00:00
Accession:  0001104659-24-089693
Event type: other_material
Sentiment:  positive
Materiality: 0.85
Item codes: 5.02, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Actuate Therapeutics completes IPO of 2.8M shares at $8.00, net proceeds $19.2M
-------------------------------------------------------------------------------

- IPO closed Aug 14, 2024: 2,800,000 shares at $8.00/share, net proceeds $19.2M.
- Underwriters granted 30-day option to purchase up to 420,000 additional shares.
- New independent directors appointed: Jason Keyes, Roger Sawhney, Amy Ronneberg; Les Kreis resigned.
- Charter amended: authorized common stock increased to 200M shares; classified board created.
- Exclusive forum provisions for federal securities law claims adopted in charter.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1652935/000110465924089693/0001104659-24-089693-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1652935/000110465924089693/tm2419022d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-089693

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer